Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.38 |
| ▸ | CSNK1E | P49674 | 6/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | CSNK1D | P48730 | 5/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | CTSS | P25774 | 1/20 | 0.36 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.36 |
| ▸ | F12 | P00748 | 1/20 | 0.36 |
| ▸ | SUV39H2 | Q9H5I1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30622773 | 0.92 | MEN1 (0.37) | MEN1KMT2AESR2CSNK1ECNR1 | |
| SCHEMBL26645726 | 0.87 | MEN1 (0.46) | MEN1KMT2AESR2CSNK1ECNR1 | |
| SCHEMBL26645805 | 0.85 | CSNK1E (0.42) | MEN1KMT2AESR2CSNK1ECNR1 | |
| SCHEMBL24277111 | 0.85 | CSNK1E (0.41) | ESR2CSNK1ELMNACSNK1DF12 | |
| SCHEMBL17382842 | 0.83 | CSNK1E (0.52) | CSNK1ECSNK1D | |
| SCHEMBL17129177 | 0.81 | CSNK1D (0.51) | CSNK1ECSNK1DPOLBGPR119 | |
| SCHEMBL26645904 | 0.81 | CSNK1E (0.55) | CSNK1ECSNK1D | |
| SCHEMBL30622973 | 0.81 | GRM5 (0.41) | MEN1KMT2ACSNK1ECNR1CNR2 | |
| SCHEMBL26645271 | 0.80 | CSNK1E (0.46) | MEN1KMT2ACSNK1ECSNK1D | |
| SCHEMBL16728627 | 0.80 | CSNK1E (0.56) | CSNK1ECSNK1D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4519265-A1 | IRREVERSIBLE MUTEGFR INHIBITORS | Bayer Aktiengesellschaft (DE) | 2025-03-12 | — | — | EP | disclosed |
| WO-2023213882-A1 | IRREVERSIBLE MUTEGFR INHIBITORS | BAYER AKTIENGESELLSCHAFT (DE) | 2023-11-09 | — | — | WO | disclosed |